KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Operating Income (2016 - 2025)

Cvs Health (CVS) has disclosed Operating Income for 17 consecutive years, with $3.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Income rose 300.13% year-over-year to $3.0 billion, compared with a TTM value of $4.7 billion through Dec 2025, down 3.0%, and an annual FY2025 reading of $4.7 billion, up 116.44% over the prior year.
  • Operating Income was $3.0 billion for Q4 2025 at Cvs Health, up from $632.0 million in the prior quarter.
  • Across five years, Operating Income topped out at $3.7 billion in Q3 2023 and bottomed at -$9.2 billion in Q4 2023.
  • Average Operating Income over 5 years is $583.6 million, with a median of $470.5 million recorded in 2024.
  • Peak annual rise in Operating Income hit 1951.19% in 2023, while the deepest fall reached 2953.56% in 2023.
  • Year by year, Operating Income stood at $2.3 billion in 2021, then plummeted by 86.23% to $323.0 million in 2022, then plummeted by 2953.56% to -$9.2 billion in 2023, then surged by 108.19% to $755.0 million in 2024, then skyrocketed by 300.13% to $3.0 billion in 2025.
  • Business Quant data shows Operating Income for CVS at $3.0 billion in Q4 2025, $632.0 million in Q3 2025, and $487.0 million in Q2 2025.